Botulinum Toxin (Botox) Injection for Pain

Medically reviewed by Joshua L. Hare, DO, Founder & Medical Director

Conditions Treated

Chronic migraine, cervical dystonia, and muscle-related (myofascial) pain.

Botulinum Toxin for Pain at a Glance

Type of procedure	Office visit; a series of small injections with a fine needle
Anesthesia	Usually none needed; sedation is not typical for this treatment
Time in the office	About 15–30 minutes
Back to activity	Same day; avoid rubbing or massaging the injected areas for the rest of that day
Effect begins	Gradually over days; it takes about two weeks[1] for the effect to fully develop
Repeat schedule	Per MedlinePlus, additional rounds may be given every 3 to 4 months,[2] depending on how long the effect lasts for you
FDA-approved pain uses	Preventing headaches in adult chronic migraine; treating cervical dystonia

How Botulinum Toxin Relieves Pain

Botulinum toxin is a purified protein that works at the junction where a nerve tells a muscle to contract. It causes a reversible inhibition of the release of acetylcholine[1] — the chemical messenger that fires the muscle — so the overactive muscle relaxes. The word to hold onto is reversible: the nerve endings recover over a few months, which is why the effect wears off and why treatment is given in cycles rather than once.

The Chronic Migraine Protocol

The best-established pain use is preventing headaches in chronic migraine. The FDA approval covers adults who have 15 or more days each month with headaches lasting 4 hours a day or longer.[2] Treatment follows a defined injection pattern across the head, neck and shoulders, repeated on a set cycle; in the pivotal trials, patients were re-treated every 12 weeks.[3]

This is preventive medicine, so the goal is fewer and milder headache days over the coming months. It is not a treatment you take on the day of an attack.

How Well Does It Work?

The evidence for chronic migraine comes from the PREEMPT program: two multicenter, randomized, double-blind trials whose pooled analysis covered 1,384 adults.[3] At 24 weeks, patients receiving onabotulinumtoxinA had 8.4 fewer headache days per month, against 6.6 fewer with placebo[3] — a difference that was statistically significant at every measured time point. Read both numbers honestly: placebo responses run high in migraine studies, and the treatment effect is the gap between the two, on top of a meaningful overall improvement. Most reported side effects were mild to moderate, and few patients stopped treatment[3] because of them.

For cervical dystonia — a disorder of involuntary neck-muscle contraction — botulinum toxin is FDA-indicated because it reduces the severity of abnormal head position and the neck pain[1] that comes with it.

The Day of the Appointment

1. Mapping. The physician confirms the injection pattern for your condition — for chronic migraine, a standardized set of sites across the head, neck and shoulders.
2. The injections. A fine needle places a small dose at each site. Each one takes seconds, and most patients tolerate the series without numbing.
3. A short check. You are observed briefly and then go home; no driver is required for a routine visit.
4. The rest of the day. Normal activity is fine. Leave the injected areas alone — no rubbing or massage until the next day.

FDA-Approved Uses and Off-Label Use

OnabotulinumtoxinA is FDA-approved for preventing chronic migraine in adults and for treating cervical dystonia, among other non-pain indications. Its use for other pain problems — including muscle-related (myofascial) pain — is decided case by case and may fall outside the approved labeling. If your physician recommends an off-label use, they will say so during the consultation and explain why.

Risks and Side Effects

The most common effects are local and short-lived: tenderness or a small bruise where the needle went in. Because the medication weakens muscle activity where it is placed, unwanted weakness in nearby muscles can occur and can last up to 3 months[1] when it does.

There is also a boxed warning to know about. MedlinePlus states that the medication may spread from the area of injection[2] and, if it reaches the muscles that control breathing or swallowing, can cause serious problems — and it also notes that no one has yet developed these symptoms after receiving recommended doses for headaches.[2] Report any trouble swallowing, speaking or breathing after treatment right away. Tell the team about muscle or nerve conditions and every medication you take before your first round.

Common Questions

How soon will I know whether it is working?

Give it time to develop — the effect builds over days and takes about two weeks to fully arrive. For migraine prevention, the real measure is your headache count across the following weeks, which is why a simple headache diary is worth keeping through the first cycle.

Is this the same product used for cosmetic wrinkle treatment?

Same medication, different job. The doses, injection sites and treatment goals for chronic migraine or cervical dystonia are specific to those conditions, and the treatment here is planned by a pain physician around your diagnosis.

Why does treatment repeat every three months?

Because the effect wears off on its own. The affected nerve endings recover their signaling over a few months, the muscle activity returns, and with it the symptoms — so the treatment cycle is matched to how long the effect lasts in you.

What if it does not help my headaches?

Botox for headache is judged over a full treatment cycle rather than a single visit, so the first review point is after that cycle. If your headaches have not moved by then, your physician re-examines the diagnosis before recommending the next step. Other interventional options for head pain exist, including the occipital nerve block.

References

Clinical sources for this page.

1. Botulinum Toxin. StatPearls [Internet], National Library of Medicine; updated November 6, 2023. Back to first citation ↑
2. National Library of Medicine, MedlinePlus Drug Information. OnabotulinumtoxinA Injection. Back to first citation ↑
3. Dodick DW, Turkel CC, DeGryse RE, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–936. Back to first citation ↑